These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [What does the x-ray examination of the gallbladder achieve in ambulatory practice? Technic and evaluation of cholecystography]. Bopp J Med Welt; 1968 Sep; 39():2082-5. PubMed ID: 5717140 [No Abstract] [Full Text] [Related]
43. [Cholecystography in the clinical course of professional diseases]. Kleĭner AI; Levendiuk AM; Timofeev NV Vrach Delo; 1967 Nov; 11():97-9. PubMed ID: 5621444 [No Abstract] [Full Text] [Related]
45. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography]. Ipinza I Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610 [No Abstract] [Full Text] [Related]
46. Cholecystokinin cholecystography in the diagnosis of acalculous extrahepatic biliary tract disorders. Neschis M; King MC; Murphy RA Am J Gastroenterol; 1978 Dec; 70(6):593-9. PubMed ID: 742610 [TBL] [Abstract][Full Text] [Related]
47. ["Caerulein" in the clinical radiological study of the biliary tract]. Braibanti T; Bertaccini G; Uva F Ann Radiol Diagn (Bologna); 1968; 41(6):516-32. PubMed ID: 5716507 [No Abstract] [Full Text] [Related]
48. A weighed dietary survey of men in Caerphilly, South Wales. Fehilly AM; Phillips KM; Sweetnam PM Hum Nutr Appl Nutr; 1984 Aug; 38(4):270-6. PubMed ID: 6490395 [TBL] [Abstract][Full Text] [Related]
49. [Infusion cholangio-cholecystography]. Crocellà A; Nannelli U; Bruno S; Vita G Fortschr Geb Rontgenstr Nuklearmed; 1970 Sep; 113(3):359-66. PubMed ID: 5533869 [No Abstract] [Full Text] [Related]
50. [Experience with combined cholecysto-cholangiography in diseases of the biliary tract]. Shpil't MM Klin Med (Mosk); 1966 Oct; 44(10):88-94. PubMed ID: 6000668 [No Abstract] [Full Text] [Related]
51. [Technical variations in oral and intravenous radiographic diagnosis of biliary diseases]. Lagemann K Rontgenpraxis; 1972 Feb; 25(2):25-33. PubMed ID: 5020124 [No Abstract] [Full Text] [Related]
52. [Physiological or pathological value of prolonged persistence of gallbladder opacification after oral cholecystography (author's transl)]. Dayras M; Buchet R J Radiol Electrol Med Nucl; 1974 Apr; 55(4):289-95. PubMed ID: 4427299 [No Abstract] [Full Text] [Related]
53. [Ipodate as a biliary contrast medium for oral administration. Its power of opacification of the common bile duct and gallbladder as related to some indices of hepatic function]. Arena GC; Zanini E Minerva Radiol; 1970; 15(7):199-206. PubMed ID: 5498898 [No Abstract] [Full Text] [Related]
54. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study. Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767 [TBL] [Abstract][Full Text] [Related]
55. [Use of the new peptide, caeruleine, in the study of the biliary tract]. Orlandini I; Agosti A Radiol Med; 1969 Nov; 55(11):1061-70. PubMed ID: 5205470 [No Abstract] [Full Text] [Related]
56. [When cholangiocholecystography should and should not be performed]. Vidal B Minerva Med; 1975 Apr; 66(30):1417-20. PubMed ID: 1143686 [TBL] [Abstract][Full Text] [Related]
57. [Our experience with the use of biloptin and bilivistan in the study of the biliary tract]. Bini F; Bocchi R Ann Radiol Diagn (Bologna); 1970; 43(1):56-69. PubMed ID: 5496469 [No Abstract] [Full Text] [Related]
58. THE EFFECT OF PARTIAL HYDROGENATION OF DIETARY FATS, OF THE RATIO OF POLYUNSATURATED TO SATURATED FATTY ACIDS, AND OF DIETARY CHOLESTEROL UPON PLASMA LIPIDS IN MAN. ERICKSON BA; COOTS RH; MATTSON FH; KLIGMAN AM J Clin Invest; 1964 Nov; 43(11):2017-25. PubMed ID: 14223915 [No Abstract] [Full Text] [Related]